These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22998478)

  • 1. Non-amyloid and amyloid prion protein deposits in prion-infected mice differ in blockage of interstitial brain fluid.
    Rangel A; Race B; Striebel J; Chesebro B
    Neuropathol Appl Neurobiol; 2013 Apr; 39(3):217-30. PubMed ID: 22998478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unusual cerebral vascular prion protein amyloid distribution in scrapie-infected transgenic mice expressing anchorless prion protein.
    Rangel A; Race B; Klingeborn M; Striebel J; Chesebro B
    Acta Neuropathol Commun; 2013 Jun; 1():25. PubMed ID: 24252347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct patterns of spread of prion infection in brains of mice expressing anchorless or anchored forms of prion protein.
    Rangel A; Race B; Phillips K; Striebel J; Kurtz N; Chesebro B
    Acta Neuropathol Commun; 2014 Jan; 2():8. PubMed ID: 24447368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring.
    Chesebro B; Race B; Meade-White K; Lacasse R; Race R; Klingeborn M; Striebel J; Dorward D; McGovern G; Jeffrey M
    PLoS Pathog; 2010 Mar; 6(3):e1000800. PubMed ID: 20221436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anchorless prion protein results in infectious amyloid disease without clinical scrapie.
    Chesebro B; Trifilo M; Race R; Meade-White K; Teng C; LaCasse R; Raymond L; Favara C; Baron G; Priola S; Caughey B; Masliah E; Oldstone M
    Science; 2005 Jun; 308(5727):1435-9. PubMed ID: 15933194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructure and pathology of prion protein amyloid accumulation and cellular damage in extraneural tissues of scrapie-infected transgenic mice expressing anchorless prion protein.
    Race B; Jeffrey M; McGovern G; Dorward D; Chesebro B
    Prion; 2017 Jul; 11(4):234-248. PubMed ID: 28759310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased infectivity of anchorless mouse scrapie prions in transgenic mice overexpressing human prion protein.
    Race B; Phillips K; Meade-White K; Striebel J; Chesebro B
    J Virol; 2015 Jun; 89(11):6022-32. PubMed ID: 25810548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion-associated cerebral amyloid angiopathy is not exacerbated by human phosphorylated tau aggregates in scrapie-infected mice expressing anchorless prion protein.
    Race B; Williams K; Striebel JF; Chesebro B
    Neurobiol Dis; 2020 Oct; 144():105057. PubMed ID: 32829029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gerstmann-Sträussler-Scheinker disease and "anchorless prion protein" mice share prion conformational properties diverging from sporadic Creutzfeldt-Jakob disease.
    Zanusso G; Fiorini M; Ferrari S; Meade-White K; Barbieri I; Brocchi E; Ghetti B; Monaco S
    J Biol Chem; 2014 Feb; 289(8):4870-81. PubMed ID: 24398683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of the anti-prionic activity of newly synthesized congo red derivatives.
    Poli G; Ponti W; Carcassola G; Ceciliani F; Colombo L; Dall'Ara P; Gervasoni M; Giannino ML; Martino PA; Pollera C; Villa S; Salmona M
    Arzneimittelforschung; 2003; 53(12):875-88. PubMed ID: 14750496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylated human tau associates with mouse prion protein amyloid in scrapie-infected mice but does not increase progression of clinical disease.
    Race B; Phillips K; Kraus A; Chesebro B
    Prion; 2016 Jul; 10(4):319-30. PubMed ID: 27463540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prion seeding activities of mouse scrapie strains with divergent PrPSc protease sensitivities and amyloid plaque content using RT-QuIC and eQuIC.
    Vascellari S; Orrù CD; Hughson AG; King D; Barron R; Wilham JM; Baron GS; Race B; Pani A; Caughey B
    PLoS One; 2012; 7(11):e48969. PubMed ID: 23139828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crucial role for prion protein membrane anchoring in the neuroinvasion and neural spread of prion infection.
    Klingeborn M; Race B; Meade-White KD; Rosenke R; Striebel JF; Chesebro B
    J Virol; 2011 Feb; 85(4):1484-94. PubMed ID: 21123371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical and classical forms of the disease-associated state of the prion protein exhibit distinct neuronal tropism, deposition patterns, and lesion profiles.
    Kovacs GG; Makarava N; Savtchenko R; Baskakov IV
    Am J Pathol; 2013 Nov; 183(5):1539-1547. PubMed ID: 24012784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuropathological phenotype in transgenic mice expressing different prion protein constructs.
    DeArmond SJ; Yang SL; Cayetano-Canlas J; Groth D; Prusiner SB
    Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):415-23. PubMed ID: 7913760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prion protein protease sensitivity, stability and seeding activity in variably protease sensitive prionopathy brain tissue suggests molecular overlaps with sporadic Creutzfeldt-Jakob disease.
    Peden AH; Sarode DP; Mulholland CR; Barria MA; Ritchie DL; Ironside JW; Head MW
    Acta Neuropathol Commun; 2014 Oct; 2():152. PubMed ID: 25331173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards authentic transgenic mouse models of heritable PrP prion diseases.
    Watts JC; Giles K; Bourkas ME; Patel S; Oehler A; Gavidia M; Bhardwaj S; Lee J; Prusiner SB
    Acta Neuropathol; 2016 Oct; 132(4):593-610. PubMed ID: 27350609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel form of human disease with a protease-sensitive prion protein and heterozygosity methionine/valine at codon 129: Case report.
    Rodríguez-Martínez AB; Garrido JM; Zarranz JJ; Arteagoitia JM; de Pancorbo MM; Atarés B; Bilbao MJ; Ferrer I; Juste RA
    BMC Neurol; 2010 Oct; 10():99. PubMed ID: 20973975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting prion amyloid deposits in vivo.
    Sadowski M; Pankiewicz J; Scholtzova H; Tsai J; Li Y; Carp RI; Meeker HC; Gambetti P; Debnath M; Mathis CA; Shao L; Gan WB; Klunk WE; Wisniewski T
    J Neuropathol Exp Neurol; 2004 Jul; 63(7):775-84. PubMed ID: 15290902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two alternative pathways for generating transmissible prion disease de novo.
    Makarava N; Savtchenko R; Baskakov IV
    Acta Neuropathol Commun; 2015 Nov; 3():69. PubMed ID: 26556038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.